273 related articles for article (PubMed ID: 17563154)
1. Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.
Hofmann SG; Meuret AE; Rosenfield D; Suvak MK; Barlow DH; Gorman JM; Shear MK; Woods SW
J Consult Clin Psychol; 2007 Jun; 75(3):374-9. PubMed ID: 17563154
[TBL] [Abstract][Full Text] [Related]
2. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
Barlow DH; Gorman JM; Shear MK; Woods SW
JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
[TBL] [Abstract][Full Text] [Related]
3. Physical, mental, and social catastrophic cognitions as prognostic factors in cognitive-behavioral and pharmacological treatments for panic disorder.
Hicks TV; Leitenberg H; Barlow DH; Gorman JM; Shear MK; Woods SW
J Consult Clin Psychol; 2005 Jun; 73(3):506-14. PubMed ID: 15982148
[TBL] [Abstract][Full Text] [Related]
4. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.
Noda Y; Nakano Y; Lee K; Ogawa S; Kinoshita Y; Funayama T; Watanabe N; Chen J; Noguchi Y; Kataoka M; Suzuki M; Furukawa TA
BMC Psychiatry; 2007 Dec; 7():70. PubMed ID: 18067686
[TBL] [Abstract][Full Text] [Related]
6. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy.
Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S
Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790
[TBL] [Abstract][Full Text] [Related]
7. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O
Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444
[TBL] [Abstract][Full Text] [Related]
8. Cost-efficacy of individual and combined treatments for panic disorder.
McHugh RK; Otto MW; Barlow DH; Gorman JM; Shear MK; Woods SW
J Clin Psychiatry; 2007 Jul; 68(7):1038-44. PubMed ID: 17685740
[TBL] [Abstract][Full Text] [Related]
9. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.
Aaronson CJ; Shear MK; Goetz RR; Allen LB; Barlow DH; White KS; Ray S; Money R; Saksa JR; Woods SW; Gorman JM
J Clin Psychiatry; 2008 Mar; 69(3):418-24. PubMed ID: 18278989
[TBL] [Abstract][Full Text] [Related]
10. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia.
Vos SP; Huibers MJ; Diels L; Arntz A
Psychol Med; 2012 Dec; 42(12):2661-72. PubMed ID: 22717019
[TBL] [Abstract][Full Text] [Related]
12. [Coincidence of schizophrenia and panic disorder].
Rupprecht R; Ströhle A
Nervenarzt; 1999 Mar; 70(3):265-8. PubMed ID: 10231815
[TBL] [Abstract][Full Text] [Related]
13. Emotion Regulation Strategies in Cognitive Behavioral Therapy for Panic Disorder.
Strauss AY; Kivity Y; Huppert JD
Behav Ther; 2019 May; 50(3):659-671. PubMed ID: 31030881
[TBL] [Abstract][Full Text] [Related]
14. Panic disorder--it's real and it's treatable.
Glass RM
JAMA; 2000 May; 283(19):2573-4. PubMed ID: 10815122
[No Abstract] [Full Text] [Related]
15. Discussion of "methodological controversies in the treatment of panic disorder".
Klein DF
Behav Res Ther; 1996; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537
[No Abstract] [Full Text] [Related]
16. Cognitive mediation of clinical improvement after intensive exposure therapy of agoraphobia and social phobia.
Vögele C; Ehlers A; Meyer AH; Frank M; Hahlweg K; Margraf J
Depress Anxiety; 2010 Mar; 27(3):294-301. PubMed ID: 20037922
[TBL] [Abstract][Full Text] [Related]
17. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Mavissakalian MR; Perel JM
Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
[TBL] [Abstract][Full Text] [Related]
18. Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.
Gelder MG
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):2S-5S. PubMed ID: 9872706
[TBL] [Abstract][Full Text] [Related]
19. Improvement in adult anxious and avoidant attachment during cognitive behavioral therapy for panic disorder.
Zalaznik D; Weiss M; Huppert JD
Psychother Res; 2019 Apr; 29(3):337-353. PubMed ID: 28826378
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of change in cognitive-behavioral treatment of panic disorder: evidence for the fear of fear mediational hypothesis.
Smits JA; Powers MB; Cho Y; Telch MJ
J Consult Clin Psychol; 2004 Aug; 72(4):646-52. PubMed ID: 15301649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
